Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
US8367077B2 · kind B2 · utility
19Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2008 |
| Grant date | Feb 5, 2013 |
| Priority date | — |
| Expiry date | Jul 24, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.